LinkedIn Profile

Access Molecular Partners historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:molecularpartners 639155 May 30th, 2019 12:00AM Molecular Partners AG, Zurich, Switzerland 1.5K 106.00 Open Biotechnology May 29th, 2019 09:27PM May 29th, 2019 09:27PM About Molecular Partners AG Molecular Partners AG is a clinical-stage biotech company that is developing a new class of therapies known as DARPin® therapeutics. The company continues to attract talented individuals who share the passion to develop breakthrough medicines for serious diseases. Molecular Partners has compounds in various stages of clinical and preclinical development and several more in the research stage, with a current focus on oncology and immuno-oncology. The company establishes research and development partnerships with leading pharmaceutical companies and is backed by established biotech investors. Open Intellectual Property of DARPins, Immunology and other Indications, Ophthalmology, Collaborations with leading pharmaceutical companies, Oncology Open Wagistrasse 14 Schlieren-Zurcih CH 8952 Molecular Partners Health Care Equipment & Services
private:molecularpartners 639155 Mar 9th, 2018 12:00AM Molecular Partners AG, Zurich, Switzerland 1.1K 89.00 Open Biotechnology Mar 8th, 2018 11:28PM Mar 8th, 2018 11:28PM Open Molecular Partners Health Care Equipment & Services
private:molecularpartners 639155 Feb 17th, 2018 12:00AM Molecular Partners AG, Zurich, Switzerland 1.0K 89.00 Open Biotechnology Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Molecular Partners is a thriving and steadily growing clinical-stage biopharmaceutical company working to advance modern medicine and significantly improve the management of serious diseases. We are developing a powerful new class of potent, specific and versatile small protein therapies called DARPins. The development of a broad portfolio of therapeutic product candidates in oncology and ophthalmology allowed a successful listing of the company on the SIX Swiss Exchange (MOLN). Molecular Partners Health Care Equipment & Services
private:molecularpartners 639155 Feb 16th, 2018 12:00AM Molecular Partners AG, Zurich, Switzerland 1.0K 89.00 Open Biotechnology Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Molecular Partners is a thriving and steadily growing clinical-stage biopharmaceutical company working to advance modern medicine and significantly improve the management of serious diseases. We are developing a powerful new class of potent, specific and versatile small protein therapies called DARPins. The development of a broad portfolio of therapeutic product candidates in oncology and ophthalmology allowed a successful listing of the company on the SIX Swiss Exchange (MOLN). Molecular Partners Health Care Equipment & Services
private:molecularpartners 639155 Feb 15th, 2018 12:00AM Molecular Partners AG, Zurich, Switzerland 1.0K 89.00 Open Biotechnology Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Molecular Partners is a thriving and steadily growing clinical-stage biopharmaceutical company working to advance modern medicine and significantly improve the management of serious diseases. We are developing a powerful new class of potent, specific and versatile small protein therapies called DARPins. The development of a broad portfolio of therapeutic product candidates in oncology and ophthalmology allowed a successful listing of the company on the SIX Swiss Exchange (MOLN). Molecular Partners Health Care Equipment & Services
private:molecularpartners 639155 Feb 14th, 2018 12:00AM Molecular Partners AG, Zurich, Switzerland 1.0K 89.00 Open Biotechnology Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Molecular Partners is a thriving and steadily growing clinical-stage biopharmaceutical company working to advance modern medicine and significantly improve the management of serious diseases. We are developing a powerful new class of potent, specific and versatile small protein therapies called DARPins. The development of a broad portfolio of therapeutic product candidates in oncology and ophthalmology allowed a successful listing of the company on the SIX Swiss Exchange (MOLN). Molecular Partners Health Care Equipment & Services
private:molecularpartners 639155 Feb 13th, 2018 12:00AM Molecular Partners AG, Zurich, Switzerland 1.0K 89.00 Open Biotechnology Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Molecular Partners is a thriving and steadily growing clinical-stage biopharmaceutical company working to advance modern medicine and significantly improve the management of serious diseases. We are developing a powerful new class of potent, specific and versatile small protein therapies called DARPins. The development of a broad portfolio of therapeutic product candidates in oncology and ophthalmology allowed a successful listing of the company on the SIX Swiss Exchange (MOLN). Molecular Partners Health Care Equipment & Services
private:molecularpartners 639155 Feb 12th, 2018 12:00AM Molecular Partners AG, Zurich, Switzerland 1.0K 89.00 Open Biotechnology Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Molecular Partners is a thriving and steadily growing clinical-stage biopharmaceutical company working to advance modern medicine and significantly improve the management of serious diseases. We are developing a powerful new class of potent, specific and versatile small protein therapies called DARPins. The development of a broad portfolio of therapeutic product candidates in oncology and ophthalmology allowed a successful listing of the company on the SIX Swiss Exchange (MOLN). Molecular Partners Health Care Equipment & Services
private:molecularpartners 639155 Feb 11th, 2018 12:00AM Molecular Partners AG, Zurich, Switzerland 1.0K 89.00 Open Biotechnology Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Molecular Partners is a thriving and steadily growing clinical-stage biopharmaceutical company working to advance modern medicine and significantly improve the management of serious diseases. We are developing a powerful new class of potent, specific and versatile small protein therapies called DARPins. The development of a broad portfolio of therapeutic product candidates in oncology and ophthalmology allowed a successful listing of the company on the SIX Swiss Exchange (MOLN). Molecular Partners Health Care Equipment & Services
private:molecularpartners 639155 Feb 10th, 2018 12:00AM Molecular Partners AG, Zurich, Switzerland 1.0K 89.00 Open Biotechnology Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Molecular Partners is a thriving and steadily growing clinical-stage biopharmaceutical company working to advance modern medicine and significantly improve the management of serious diseases. We are developing a powerful new class of potent, specific and versatile small protein therapies called DARPins. The development of a broad portfolio of therapeutic product candidates in oncology and ophthalmology allowed a successful listing of the company on the SIX Swiss Exchange (MOLN). Molecular Partners Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.